Roger Sun

Roger Sun has over 25 years of experience in business development, venture development and investment, corporate strategy and planning, alliance/partnership management, portfolio management, new product development, marketing strategy and clinical practice from various roles in biotechnology industry. Dr. Sun is the CEO and founder of Simedice Biotechnologies, Inc. which develops, manufactures, and markets high-end hydrophobic intraocular lens products including trifocal lens, trifocal toric lens and EDOF lens to treat global cataract patients.